NMIN’s first round of research investment
An update from the NanoMedicines Innovation Network (NMIN): On August 21, 2019, the Board of Directors approved NMIN's initial investments of $4.3M in nanomedicines research. Over a two-year period, NMIN will support 20 innovative projects led by Canadian leaders in nanomedicine drug delivery, gene therapy and diagnostics. These projects, hosted at six [...]









